BiotechTube

Fibrin Sealant Vapor-Heated Solvent/Detergent-treated

Phase 3Completed
0 watching 0 views this week📈 Rising
74
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Hip Replacement Surgery

Conditions

Hip Replacement Surgery

Trial Timeline

Aug 1, 2001 → Mar 1, 2003

NCT ID
NCT00161902

About Fibrin Sealant Vapor-Heated Solvent/Detergent-treated

Fibrin Sealant Vapor-Heated Solvent/Detergent-treated is a phase 3 stage product being developed by Baxter for Hip Replacement Surgery. The current trial status is completed. This product is registered under clinical trial identifier NCT00161902. Target conditions include Hip Replacement Surgery.

Hype Score Breakdown

Clinical
27
Activity
18
Company
7
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT00161902Phase 3Completed

Competing Products

20 competing products in Hip Replacement Surgery

See all competitors
ProductCompanyStageHype Score
DU-176bDaiichi SankyoPhase 2
52
YM150 + WarfarinAstellas PharmaPhase 2
52
LY517717 + enoxaparinEli LillyPhase 2
52
SugammadexMerckApproved
85
LNA043 + PlaceboNovartisPhase 1
33
SBR759 + Sevelamer HCl + SBR759 + Sevelamer HClNovartisPhase 2
52
conjugated estrogens/progestin (MPA)PfizerPhase 1
32
rhBSSL + PlaceboSwedish Orphan BiovitrumPhase 2
51
rhBSSL + PlaceboSwedish Orphan BiovitrumPhase 2
51
JNJ-70033093 25 mg + JNJ-70033093 50 mg + JNJ-70033093 100 mg + JNJ-70033093 200 mg + Placebo + Enoxaparin 40 mgBristol Myers SquibbPhase 2
51
Enoxaparin sodiumSanofiPhase 3
76
HSK36273 + Heparin sodiumHaisco Pharmaceutical GroupPhase 2
49
Rivaroxaban (Xarelto, BAY59-7939) + Acetylsalicylic Acid (ASA) + Clopidogrel + Rivaroxaban (Xarelto, BAY59-7939) + Vitamin K antagonist (VKA)BayerPhase 3
74
Exacyl®BayerPhase 3
74
Rivaroxaban (Xarelto, BAY59-7939)BayerPre-clinical
20
Gynodian® Depot (BAY86-5032) + BAY86-4980BayerPhase 3
74
FLOSEAL Hemostatic Matrix + Standard of careBaxterApproved
82
OMS302 + PlaceboOmeros CorporationPhase 3
72
Part 1 OMS302 + Part 2 OMS302 + Part 2 PlaceboOmeros CorporationPhase 3
72
OMS302 + PlaceboOmeros CorporationPhase 3
72

Other Products from Baxter

FLOSEAL Hemostatic Matrix + Standard of careApproved
82
Esmolol + MetoprololApproved
82
Fibrin Sealant (Tisseel) used in the Experimental Arm.Approved
82
Sevoflurane + propofol + remifentanilApproved
82
Physioneal + Dianeal + Extraneal + NutrinealApproved
82